Hormonal Profile in Men With Premature Androgenic Alopecia

January 2000 in “ PubMed ”

Luboslav Stárka, Martin Hill, Polácek

androgenetic alopecia sexual binding globulin SHBG FSH 17 alpha-hydroxyprogesterone polycystic ovaries syndrome PCOS androgenic alopecia sex hormone-binding globulin follicle-stimulating hormone

TLDR Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

The study conducted 23 years ago involved 15 young men with premature androgenetic alopecia, a condition that can cause serious psychological trauma and financial burden due to treatments. The hormonal analysis of these men revealed a significantly lower plasma level of sexual binding globulin (SHBG) and FSH, and a nearly significantly higher concentration of 17 alpha-hydroxyprogesterone. These hormonal patterns were similar to those found in women suffering from polycystic ovaries syndrome (PCOS). The study suggested that premature balding could be a male hormonal equivalent of PCOS, aligning with previous genetic studies that indicated a common genetic basis in families where balding and excessive hair growth were frequent in male members.

View this study on pubmed.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Why you should use 0.5mg Dut instead of 1mg Fin

in Finasteride/Dutasteride 45 upvotes 2 years ago

The comparison of 0.5mg dutasteride and 1mg finasteride for treating hair loss in men with androgenetic alopecia, with discussion of which is more effective and has fewer side effects.

community The Real Cause Of Androgenetic Alopecia

in Research/Science 667 upvotes 1 month ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community Kintor Pharmaceutical Announced U.S. FDA Has Greenlighted Phase II Clinical Trial for Pyrilutamide to Treat Androgenetic Alopecia

in Treatment 26 upvotes 3 years ago

Chinese company gets green light for Pyrilutamide Phase II trial for androgenetic alopecia. Androgen receptors downregulate in androgen deficient environments.

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

in Research/Science 89 upvotes 1 year ago

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

in Research/Science 136 upvotes 7 months ago

The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

community My 3 year experience and progress pics with 6 different treatments

in Progress Pictures 39 upvotes 4 years ago

The user tried Finasteride, Dutasteride, Minoxidil, RU58841, dermarolling, and oral castor oil for hair loss. They found RU58841 and Minoxidil most effective with no side effects, while Finasteride and Dutasteride caused sexual side effects.

Related Research

1 / 1 results

research Hormonal Profile in Men With Premature Androgenic Alopecia

4 citations, January 2000 in “PubMed”

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.